Committee for Orphan Medicinal Products (COMP): 6-7 November 2012

Date: 06/11/2012 to 07/11/2012
Location: European Medicines Agency, London, UK
The Committee for Orphan Medicinal Products (COMP) is the committee that is responsible for reviewing applications for 'orphan medicinal product designation' for medicines intended for the diagnosis, prevention or treatment of rare diseases.

How useful was this page?

Add your rating